Inhibikase TherapeuticsIKT
那斯達克 · USD
2.41
-0.06
(-2.43%)
收盤 08/29 03:59 (UTC+8)
盤後
2.46
+0.05
(+2.07%)
08/29 03:59 (UTC+8)
Inhibikase TherapeuticsIKT
2.41
-0.06
(-2.43%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 21,051 | 17,842 | 13,776 | 12,769 | 10,832 | - | 12,929 | 5,828 | - | 4,782 |
研發費用 | 13,393 | 10,839 | 6,359 | 7,650 | 5,271 | 10,514 | 7,194 | 4,190 | 3,076 | 2,751 |
推銷及管理費用 | 7,658 | 7,003 | 7,417 | 5,119 | 5,561 | 4,084 | 5,735 | 1,638 | 1,975 | 2,031 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,051 | -17,842 | -13,776 | -12,768 | -10,832 | -14,598 | -12,929 | -5,827 | -5,051 | -4,782 |
其他收入及費用 | 1,460 | 1,461 | 1,041 | 838 | 917 | 919 | 796 | 49 | 91 | 133 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -19,591 | -16,381 | -12,735 | -11,930 | -9,916 | -13,679 | -12,133 | -5,778 | -4,960 | -4,650 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -19,591 | -16,381 | -12,735 | -11,930 | -9,916 | -13,679 | -12,133 | -5,778 | -4,960 | -4,650 |
基本每股稅後盈餘(元) | -0.11 | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 | 0.88 | -0.65 | -0.11 | -0.73 |
稀釋每股稅後盈餘(元) | -0.11 | -0.10 | -0.09 | -0.14 | -0.11 | -0.15 | 0.87 | -0.65 | -0.11 | -0.12 |
基本平均股數(千股) | 174571.00 | 172306.00 | 123644.00 | 90050.00 | 90009.00 | 89537.00 | 72091.00 | 8882.00 | 45213.00 | 6340.00 |
稀釋平均股數(千股) | 174571.00 | 172306.00 | 123644.00 | 90050.00 | 90009.00 | 89537.00 | 72091.00 | 8882.00 | 45213.00 | 6340.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 | 0.88 | -0.65 | -0.66 | -4.38 |
還原稀釋每股稅後盈餘(元) | -0.11 | -0.10 | -0.09 | -0.14 | -0.11 | -0.15 | 0.87 | -0.65 | -0.65 | -0.73 |
還原基本平均股數(千股) | 174,571 | 172,306 | 123,644 | 90,050 | 90,009 | 89,537 | 72,091 | 8,882 | 7,535 | 1,056 |
還原稀釋平均股數(千股) | 174,571 | 172,306 | 123,644 | 90,050 | 90,009 | 89,537 | 72,091 | 8,882 | 7,535 | 1,056 |
EBITDA(千元) | -19,591 | -16,381 | -13,672 | -11,906 | -9,892 | -13,666 | -12,126 | -5,771 | -4,953 | -4,643 |